Loading…
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia
A substantial subset of patients with T cell acute lymphoblastic leukemia (T-ALL) develops resistance to steroids and succumbs to their disease. encodes a bZIP protein that has been implicated as a T-ALL oncogene from insertional mutagenesis studies in mice, but its role in human T-ALL pathogenesis...
Saved in:
Published in: | The Journal of experimental medicine 2018-07, Vol.215 (7), p.1929-1945 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A substantial subset of patients with T cell acute lymphoblastic leukemia (T-ALL) develops resistance to steroids and succumbs to their disease.
encodes a bZIP protein that has been implicated as a T-ALL oncogene from insertional mutagenesis studies in mice, but its role in human T-ALL pathogenesis has remained obscure. Here we show that
is aberrantly expressed in a subset of T-ALL patients and is associated with poor survival. JDP2 is required for T-ALL cell survival, as its depletion by short hairpin RNA knockdown leads to apoptosis. Mechanistically, JDP2 regulates prosurvival signaling through direct transcriptional regulation of
Furthermore,
is one of few oncogenes capable of initiating T-ALL in transgenic zebrafish. Notably, thymocytes from
transgenic zebrafish express high levels of
and demonstrate resistance to steroids in vivo. These studies establish
as a novel oncogene in high-risk T-ALL and implicate overexpression of
as a mechanism of steroid resistance in
-overexpressing cells. |
---|---|
ISSN: | 0022-1007 1540-9538 |
DOI: | 10.1084/jem.20170484 |